• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Therapeutic research for mitochondrial disease

Research Project

Project/Area Number 12670723
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionTohoku University

Principal Investigator

HAGINOYA Kazuhiro  Tohoku University School of Medicine, Pediatrics, Lecturer, 大学院・医学系研究科, 講師 (00208414)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsmitochondrial disease / mitochondrial DNA / heteroplasmy / A3243G / MELAS / ヘテロプラスミー / 変異率 / 培養線維芽細胞 / 高酸素 / 低酸素
Research Abstract

This study aimed at establishing therapeutic approach to the patients with mitochondrial disease who have a heteroplasmy of normal and mutated mitochondrial DNA in their tissues. In order to investigate modifying factors on replication of mutated mitochondrial DNA in cultured fibroblasts obtained from patient with MELAS, we developed cybrid clone by fusion of Hela cell lacking mitochondrial DNA and patient's fibroblasts lacking nuclei. Two cybrid clone were obtained and the rate of mutated mitochondrial DNA(A3243G) of these clone was 11 % (clone A) and 42 % (clone B), respectively. These two cybrid clone were cultured for 72 hours under 1) variously changed oxygen concentration such as 70, 150, and 500 mmHg of pO 2, 2) variously changed glucose concentration consisted of 0, 0.01, 0.05, 0.1, 0.2, and 0.5 %, 3) conditioned medium supplied with predonisolon or insulin. Change in the rate of mutated mitochondrial DNA after conditioned culture was determined by single cell PCR followed by A … More paI RFLP. The results were statistically evaluated using Mann-Whitney U test. Significance was set at p<0.05.
Results: 1) There was no significant difference in clone A under three conditioned pO2 cultures. However, clone B showed significant decrease of mutation rate after culturing under 500 mmHg of pO2. Cell viability test that was simaltaneously studied in each culture condition showed decrease in cell viability in clone B in high oxygen concentration culture. This suggests that cells with high mitochondrial DNA mutation rate were susceptible to functional cell damage leading to selective cell death when it is subjected to reactive oxygen species that is normally produced in the mitochondria.
2) There was no significant change in the rate of mutated mitochondrial DNA in clone A under cultures with various concentration of glucose. However, clone B showed significant decrease of mutation rate in 0 % and 0.01 % of glucose concentration. Cell viability test showed decrease in viability in clone B under 0 % and 0.01 % of glucose concentration in the culture medium. This suggests that cells with relatively high mutation rate are highly dependent on glycolysis for ATP production rather than oxidative phosphorylation in the mitochondria. This caused selective cell death leading to decrease in mutation rate in cells cultured in those medium. 3) Predonisolon and insulin supplementation in the medium showed no significant changes in mutation rate in both clone A and B. Culture study supplied with other drugs that might affect on replication of mutated mitochondrial DNA is now under way. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] Katayama M, et al.: "Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy"Neurology. 58. 323-325 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Aoki M, Haginoya K, et al.: "A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease"Neurosci Lett. 312. 71-74 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Haginoya K, et al.: "Mechanism of tonic spasms in West syndrome viewed from ictal SPECT findings"Brain & Development. 23. 496-501 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Katayama M, et.al.: "Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy"Neurology. 58. 323-325 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Aoki M, Haginoya K, et. al.: "A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease"Neurosci Lett. 312. 71-74 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Haginoya K, et. al.: "Mechanism of tonic spasms in West syndrome viewed from ictal SPECT findings"Brain & Development. 23. 496-501 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Katayama M, et al.: "Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy"Neurology. 58. 323-325 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Aoki M, Haginoya K, et al.: "A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease"Neurosci Lett. 312. 71-74 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Haginoya K, et al.: "Mechanism of tonic spasums in West syndrome viewed from ictal SPECT findings"Brain & Development. 23. 496-501 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ishitobi M,Haginoya K, et al.: "Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy."NeuroReport. 11. 4033-4035 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Zhao Y,Haginoya K, et al.: "Strong immunoreactivity of platelet-derived growth factor and its receptor at the human and mouse neuromuscular junctions."Tohoku J Exp Med 1999:189;239-244.. 189. 239-244 (1999)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi